speb/financial-data huggingface dataset:
Financial ratios for SILLYMONKS.NS — quarterly report dated 2024-12-31
Total revenue: 819547.7328359948
Gross profit: 96957.68737615107
Operating income: 3811.633057465905
Net income: 15351.43956172048
Capital expenditures: 0
Depreciation & amortization: 13183.354703345378
Owner earnings: 28534.79426506586
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.2778878657186152
P/E ratio: 46.21059073652239
Shares outstanding: 10211300
Market cap (USD): 2837596.363212495
Effective tax rate (%): -230.0751879699248
Interest coverage ratio: 3.4062500000000004
COGS to revenue (%): 88.16936665291783
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SILLYMONKS.NS — annual report dated 2025-03-31
Total revenue: 3067933.130699088
Gross profit: 379810.61491699785
Operating income: 7879.354687865326
Net income: 23638.064063595975
Capital expenditures: 11047.463175122748
Operating cash flow: 12578.910451250877
Depreciation & amortization: 52349.777881692775
Net tangible assets: 864577.975216273
Owner earnings: 64940.378770166
Return on net tangible assets (%): 7.511222889285521
Capex to operating income (%): 140.20771513353114
Buffett classification: The Gruesome
Stock price: 0.15976193254755514
P/E ratio: 69.01483207058683
Shares outstanding: 10211300
Book value: 889981.2953004442
P/B ratio: 1.833046413938533
Market cap (USD): 1631377.0218228498
Debt to equity: 0.038999592796437624
Current ratio: 1.9674079445653048
Quick ratio: 1.2228265248569814
Effective tax rate (%): 27.65151515151515
Interest coverage ratio: 1.6280193236714977
COGS to revenue (%): 87.61998391958267
Free cash flow (dilution-adjusted): -2115.969137245733
Buyback yield (%): 0
Inventory turnover: 12.441402445622767
Receivables turnover: 38.42890613559818
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.8132337504072202
FCF margin (%): -0.06897051034367128
Revenue growth (%): 15.27783379774474
Rule of 40 score: 15.20886328740107
Financial ratios for SILLYMONKS.NS — quarterly report dated 2025-03-31
Total revenue: 755950.4325461772
Gross profit: 77905.0736497545
Operating income: -3822.7729717091415
Net income: -771.5688566752395
Capital expenditures: 0
Depreciation & amortization: 13198.503624035538
Net tangible assets: 864577.975216273
Owner earnings: 12426.934767360299
Buffett classification: The Gruesome
Stock price: 0.15976193254755514
Shares outstanding: 10211300
Book value: 889981.2953004442
P/B ratio: 1.833046413938533
Market cap (USD): 1631377.0218228498
Debt to equity: 0.038999592796437624
Current ratio: 1.9674079445653048
Quick ratio: 1.2228265248569814
Interest coverage ratio: -4.037037037037037
COGS to revenue (%): 89.69442038846962
Buyback yield (%): 0
Inventory turnover: 3.1381885077372575
Receivables turnover: 9.469029140430518
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.39455109255661863
Revenue growth (%): -7.760048346390155
Rule of 40 score: -7.760048346390155
Financial ratios for SILLYMONKS.NS — quarterly report dated 2025-06-30
Total revenue: 688076.2930025744
Gross profit: 50421.24970746548
Operating income: -42043.06108120758
Net income: -44172.71238006085
Capital expenditures: 0
Depreciation & amortization: 12532.178797098059
Owner earnings: -31640.533582962795
Buffett classification: The Gruesome
Stock price: 0.18698806459162182
Shares outstanding: 10211300
Market cap (USD): 1909391.2239644278
Interest coverage ratio: -55.276923076923076
COGS to revenue (%): 92.67214257775963
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -8.978649475070807
Rule of 40 score: -8.978649475070807
Financial ratios for SILLYMONKS.NS — quarterly report dated 2025-09-30
Total revenue: 731071.0259301014
Gross profit: 113370.91319052987
Operating income: 20789.177001127395
Net income: 20124.01352874859
Capital expenditures: 0
Depreciation & amortization: 12953.776775648252
Net tangible assets: 795084.5546786922
Owner earnings: 33077.79030439684
Return on net tangible assets (%): 4.160285860132721
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.17891770011273955
P/E ratio: 22.696544957983193
Shares outstanding: 10211300
Book value: 816786.9222096954
P/B ratio: 2.2367918259741337
Market cap (USD): 1826982.3111612173
Debt to equity: 0.020966472967190716
Current ratio: 1.570784563995329
Quick ratio: 1.0688699997284308
Effective tax rate (%): 1.2721238938053099
Interest coverage ratio: 38.416666666666664
COGS to revenue (%): 84.49248989914567
Buyback yield (%): 0
Inventory turnover: 2.964506005843524
Receivables turnover: 5.638782608695651
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.3717041800643086
Revenue growth (%): 6.248541530171013
Rule of 40 score: 6.248541530171013
Financial ratios for SILLYMONKS.NS — quarterly report dated 2025-12-31
Total revenue: 628439.3449927593
Gross profit: 13055.586498830346
Operating income: -76372.95310237273
Net income: -74579.48089562215
Capital expenditures: 0
Depreciation & amortization: 13946.752812743678
Owner earnings: -60632.72808287847
Buffett classification: The Gruesome
Stock price: 0.23281719950985852
Shares outstanding: 10211300
Market cap (USD): 2377366.269355018
Interest coverage ratio: -228.53333333333333
COGS to revenue (%): 97.9225383320039
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -14.038537610866122
Rule of 40 score: -14.038537610866122
Financial ratios for SOCA — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -274846
Net income: 630309
Capital expenditures: 0
Operating cash flow: -296592
Net tangible assets: 168185153
Owner earnings: 630309
Return on net tangible assets (%): 0.37477089312396084
Buffett classification: The Gruesome
Stock price: 9.96
P/E ratio: 69.92284736533986
Shares outstanding: 17700000
Book value: 168185153
P/B ratio: 1.0482019182751525
Market cap (USD): 176292000.00000003
Debt to equity: 0
Current ratio: 9.45168498778592
Quick ratio: 9.45168498778592
Free cash flow (dilution-adjusted): -296592
Buyback yield (%): 0
Retained earnings: -6075468
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.15657604491335134
Rule of 40 score: 0
Financial ratios for SOCA — annual report dated 2025-12-31
Capital expenditures: 0
Net tangible assets: 169720318
Buffett classification: The Gruesome
Stock price: 10.05
Shares outstanding: 17700000
Book value: 169720318
P/B ratio: 1.0481066857298724
Market cap (USD): 177885000
Debt to equity: 0
Current ratio: 5.055745111967673
Quick ratio: 5.055745111967673
Buyback yield (%): 0
Retained earnings: -6266610
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SOCA — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -203563
Net income: 1535165
Capital expenditures: 0
Operating cash flow: -36994
Owner earnings: 1535165
Buffett classification: The Gruesome
Stock price: 10.05
P/E ratio: 85.17520086570967
Shares outstanding: 17700000
Market cap (USD): 177885000
Free cash flow (dilution-adjusted): -36994
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for STZ — annual report dated 2022-02-28
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 199.3
Shares outstanding: 170752511
Market cap (USD): 34030975442.300003
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for STZ — annual report dated 2023-02-28
Total revenue: 10177200000
Gross profit: 4769000000
Operating income: 2840900000
Net income: -38500000
Capital expenditures: 1035400000
Operating cash flow: 2756900000
Depreciation & amortization: 383800000
Net tangible assets: -2239900000
Owner earnings: -690100000
Capex to operating income (%): 36.44619662782921
Buffett classification: The Good
Stock price: 209.58
Shares outstanding: 170752511
Book value: 8733900000
P/B ratio: 4.097403365664824
Market cap (USD): 35786311255.380005
Debt to equity: 1.483884633439815
Current ratio: 1.1778122157463868
Quick ratio: 0.5381531516356164
Effective tax rate (%): 110.03649635036497
Interest coverage ratio: 6.7176637502955785
COGS to revenue (%): 46.020516448532014
SG&A to revenue (%): 18.9452894705813
Free cash flow (dilution-adjusted): 1653000000
Buyback yield (%): 8.942525473392823
Retained earnings: 12343900000
Inventory turnover: 2.466740401327224
Receivables turnover: 9.460122699386503
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.09532589656126
FCF margin (%): 16.24218842117675
Rule of 40 score: 16.24218842117675
Financial ratios for STZ — annual report dated 2024-02-29
Total revenue: 10711000000
Gross profit: 5017500000
Operating income: 3184800000
Net income: 1765200000
Capital expenditures: 1269100000
Operating cash flow: 2780000000
Depreciation & amortization: 427900000
Net tangible assets: -968900000
Owner earnings: 924000000
Return on net tangible assets (%): -95.36587883166477
Capex to operating income (%): 39.848656116553634
Buffett classification: The Good
Stock price: 236.25
P/E ratio: 22.853093543932697
Shares outstanding: 170752511
Book value: 10064600000
P/B ratio: 4.008135516935596
Market cap (USD): 40340280723.75
Debt to equity: 1.247699858911432
Current ratio: 1.1870961581309483
Quick ratio: 0.5255753254607378
Effective tax rate (%): 20.55090467188766
Interest coverage ratio: 7.179440937781785
COGS to revenue (%): 46.160956026514796
SG&A to revenue (%): 17.11044720380917
Free cash flow (dilution-adjusted): 1447300000
Buyback yield (%): 0.6189842894499027
Retained earnings: 13417200000
Inventory turnover: 2.379011692248472
Receivables turnover: 9.913003239241093
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.123281596452328
FCF margin (%): 13.512277098310149
Revenue growth (%): 5.24505757968793
Rule of 40 score: 18.757334677998077
Financial ratios for STZ — quarterly report dated 2024-08-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 230.71
Shares outstanding: 170752511
Market cap (USD): 39394311812.81
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for STZ — quarterly report dated 2024-11-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 231.92
Shares outstanding: 170752511
Market cap (USD): 39600922351.119995
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for STZ — annual report dated 2025-02-28
Total revenue: 10956900000
Gross profit: 5314600000
Operating income: 3364600000
Net income: -31100000
Capital expenditures: 1214100000
Operating cash flow: 3152200000
Depreciation & amortization: 445700000
Net tangible assets: -777100000
Owner earnings: -799500000
Capex to operating income (%): 36.084527135469294
Buffett classification: The Good
Stock price: 169.93
Shares outstanding: 170752511
Book value: 7134800000
P/B ratio: 4.066823764398442
Market cap (USD): 29015974194.23
Debt to equity: 1.6978051241800751
Current ratio: 0.9209952418715305
Quick ratio: 0.5648295003965107
Interest coverage ratio: 8.041586998087954
COGS to revenue (%): 44.66683094670938
SG&A to revenue (%): 17.797004627221202
Free cash flow (dilution-adjusted): 1865900000
Buyback yield (%): 3.873039011123309
Retained earnings: 12603400000
Inventory turnover: 3.40530197606457
Receivables turnover: 11.205665780323175
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 19.098489535735165
FCF margin (%): 17.029451760990792
Revenue growth (%): 2.295770703015591
Rule of 40 score: 19.325222464006384
Financial ratios for STZ — quarterly report dated 2025-02-28
Total revenue: 2312700000
Gross profit: 1114700000
Operating income: 609400000
Net income: -370600000
Capital expenditures: 282600000
Operating cash flow: 594700000
Depreciation & amortization: 105900000
Net tangible assets: -777100000
Owner earnings: -547300000
Capex to operating income (%): 46.37348211355432
Buffett classification: The Good
Stock price: 169.93
Shares outstanding: 170752511
Book value: 7134800000
P/B ratio: 4.066823764398442
Market cap (USD): 29015974194.23
Debt to equity: 1.6978051241800751
Current ratio: 0.9209952418715305
Quick ratio: 0.5648295003965107
Interest coverage ratio: 6.081836327345309
COGS to revenue (%): 45.37985903921823
SG&A to revenue (%): 21.84892117438492
Free cash flow (dilution-adjusted): 300600000
Buyback yield (%): 1.5705142172707705
Retained earnings: 12603400000
Inventory turnover: 0.7302393543000278
Receivables turnover: 2.365207608917979
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.4591391318661984
FCF margin (%): 12.997794785315865
Rule of 40 score: 12.997794785315865
Financial ratios for STZ — quarterly report dated 2025-05-31
Total revenue: 2677500000
Gross profit: 1266600000
Operating income: 765900000
Net income: 523800000
Capital expenditures: 192800000
Operating cash flow: 637200000
Depreciation & amortization: 105200000
Net tangible assets: -424800000
Owner earnings: 436200000
Return on net tangible assets (%): -102.68361581920904
Capex to operating income (%): 25.172999086042562
Buffett classification: The Good
Stock price: 173.58
P/E ratio: 193.4674990821149
Shares outstanding: 170752511
Book value: 7532100000
P/B ratio: 3.9350540831082967
Market cap (USD): 29639220859.38
Debt to equity: 1.5356938967884122
Current ratio: 1.066917517121897
Quick ratio: 0.6847134620069841
Effective tax rate (%): 14.327772325809619
Interest coverage ratio: 7.613320079522863
COGS to revenue (%): 46.625583566760035
SG&A to revenue (%): 18.70028011204482
Free cash flow (dilution-adjusted): 434000000
Buyback yield (%): 1.0327531936559922
Retained earnings: 12938900000
Inventory turnover: 0.8841985976343933
Receivables turnover: 3.2921431206196976
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.124705147399373
FCF margin (%): 16.209150326797385
Revenue growth (%): 15.773770917109871
Rule of 40 score: 31.982921243907256
Financial ratios for STZ — quarterly report dated 2025-08-31
Total revenue: 2653900000
Gross profit: 1310000000
Operating income: 874000000
Net income: 486100000
Capital expenditures: 217300000
Operating cash flow: 852100000
Depreciation & amortization: 102700000
Net tangible assets: -212300000
Owner earnings: 371500000
Return on net tangible assets (%): -174.98822421102213
Capex to operating income (%): 24.862700228832953
Buffett classification: The Great
Stock price: 158.58
P/E ratio: 42.355597050492726
Shares outstanding: 170752511
Book value: 7786300000
P/B ratio: 3.4776380558647886
Market cap (USD): 27077933194.38
Debt to equity: 1.3542889434005883
Current ratio: 1.0825374144543882
Quick ratio: 0.5411747010603896
Effective tax rate (%): 37.91033337591008
Interest coverage ratio: 9.820224719101123
COGS to revenue (%): 44.12374241682053
SG&A to revenue (%): 16.428652172274766
Free cash flow (dilution-adjusted): 613100000
Buyback yield (%): 1.1001578217270618
Retained earnings: 13225500000
Inventory turnover: 0.8133638952559561
Receivables turnover: 2.8053911205073994
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.658848614072494
FCF margin (%): 23.101850107389126
Revenue growth (%): -0.8814192343604109
Rule of 40 score: 22.220430873028715
Financial ratios for STZ — quarterly report dated 2025-11-30
Total revenue: 2374400000
Gross profit: 1183200000
Operating income: 692000000
Net income: 522200000
Capital expenditures: 246000000
Operating cash flow: 616900000
Depreciation & amortization: 99000000
Net tangible assets: -12500000
Owner earnings: 375200000
Return on net tangible assets (%): -3001.6
Capex to operating income (%): 35.54913294797688
Buffett classification: The Good
Stock price: 134.6
P/E ratio: 19.78759189031425
Shares outstanding: 170752511
Book value: 8000300000
P/B ratio: 2.87280326745247
Market cap (USD): 22983287980.6
Debt to equity: 1.3329250153119259
Current ratio: 1.3386250690226393
Quick ratio: 0.7039849070495122
Effective tax rate (%): 17.412620591491383
Interest coverage ratio: 7.990762124711316
COGS to revenue (%): 43.78369272237197
SG&A to revenue (%): 20.68733153638814
Free cash flow (dilution-adjusted): 355000000
Buyback yield (%): 0.9576523610798618
Retained earnings: 13550400000
Inventory turnover: 0.75377030162413
Receivables turnover: 3.352251870676267
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.546862666707671
FCF margin (%): 14.951145552560646
Revenue growth (%): -10.531670371905498
Rule of 40 score: 4.419475180655148
Financial ratios for UG — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 13.33
Shares outstanding: 4594319
Market cap (USD): 61242272.27
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for UG — annual report dated 2022-12-31
Total revenue: 12698503
Gross profit: 6702127
Operating income: 4037230
Net income: 2569512
Capital expenditures: 75179
Operating cash flow: 2525169
Depreciation & amortization: 135396
Net tangible assets: 9266644
Owner earnings: 2629729
Return on net tangible assets (%): 28.37843991848613
Capex to operating income (%): 1.8621431030681928
Buffett classification: The Great
Stock price: 8.87
P/E ratio: 15.859668890435225
Shares outstanding: 4594319
Book value: 9266644
P/B ratio: 4.397666461558251
Market cap (USD): 40751609.529999994
Debt to equity: 0
Current ratio: 7.258277152576525
Quick ratio: 6.041109681871688
Effective tax rate (%): 20.39136469538492
COGS to revenue (%): 47.22112519877343
R&D to revenue (%): 3.864786266538662
Free cash flow (dilution-adjusted): 2449990
Buyback yield (%): 0
Retained earnings: 8807212
Inventory turnover: 3.5863235431324654
Receivables turnover: 8.89515024068771
Capitalized R&D asset: 490770
ROCI (R&D-adjusted, %): 44.72916696985492
FCF margin (%): 19.293534048855996
Rule of 40 score: 19.293534048855996
Financial ratios for UG — annual report dated 2023-12-31
Total revenue: 10885154
Gross profit: 5405588
Operating income: 2863032
Net income: 2581370
Capital expenditures: 165716
Operating cash flow: 3144480
Depreciation & amortization: 105682
Net tangible assets: 11388582
Owner earnings: 2521336
Return on net tangible assets (%): 22.13915656927263
Capex to operating income (%): 5.7881295074592245
Buffett classification: The Great
Stock price: 6.19
P/E ratio: 11.016954024413394
Shares outstanding: 4594319
Book value: 11388582
P/B ratio: 2.4971356934515643
Market cap (USD): 28438834.610000003
Debt to equity: 0
Current ratio: 7.986094237206829
Quick ratio: 7.188635403739663
Effective tax rate (%): 20.592239765373087
COGS to revenue (%): 50.339811453287666
R&D to revenue (%): 4.262613096700331
Free cash flow (dilution-adjusted): 2978764
Buyback yield (%): 0
Retained earnings: 10929150
Inventory turnover: 4.478577138158701
Receivables turnover: 6.947206445588858
Capitalized R&D asset: 792807.9
ROCI (R&D-adjusted, %): 24.699726588671133
Rosenberg metric: -2.641846486134034
FCF margin (%): 27.365382244477203
Revenue growth (%): -14.280021826194789
Rule of 40 score: 13.085360418282415
Financial ratios for UG — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 14.45
Shares outstanding: 4594319
Market cap (USD): 66387909.55
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for UG — annual report dated 2024-12-31
Total revenue: 12181971
Gross profit: 6460387
Operating income: 3646789
Net income: 3250875
Capital expenditures: 433077
Operating cash flow: 3466251
Depreciation & amortization: 95885
Net tangible assets: 11882866
Owner earnings: 2913683
Return on net tangible assets (%): 24.52003582300768
Capex to operating income (%): 11.875570536162087
Buffett classification: The Great
Stock price: 8.7
P/E ratio: 12.295328273157226
Shares outstanding: 4594319
Book value: 11882866
P/B ratio: 3.363715058303274
Market cap (USD): 39970575.3
Debt to equity: 0
Current ratio: 6.61569918342893
Quick ratio: 5.857266949739066
Effective tax rate (%): 20.87357857219876
COGS to revenue (%): 46.967637667172255
R&D to revenue (%): 3.7496313199235165
Free cash flow (dilution-adjusted): 3033174
Buyback yield (%): 0
Retained earnings: 11423434
Inventory turnover: 3.940498417694276
Receivables turnover: 8.528074738091155
Capitalized R&D asset: 929607.74
ROCI (R&D-adjusted, %): 28.355604132799833
Rosenberg metric: 2.273312901946585
FCF margin (%): 24.89887720139869
Revenue growth (%): 11.913630252727705
Rule of 40 score: 36.8125074541264
Financial ratios for UG — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.7
Shares outstanding: 4594319
Market cap (USD): 39970575.3
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for UG — quarterly report dated 2025-03-31
Total revenue: 2481127
Gross profit: 1358051
Operating income: 610922
Net income: 560895
Capital expenditures: 3608
Operating cash flow: 322080
Depreciation & amortization: 25030
Net tangible assets: 10835749
Owner earnings: 582317
Return on net tangible assets (%): 5.374035518910598
Capex to operating income (%): 0.5905827585190908
Buffett classification: The Great
Stock price: 8.44
P/E ratio: 17.28311553855891
Shares outstanding: 4594319
Book value: 10835749
P/B ratio: 3.5785299530286276
Market cap (USD): 38776052.36
Debt to equity: 0
Current ratio: 6.065151236902365
Quick ratio: 5.285408878638002
Effective tax rate (%): 20.77295436600142
COGS to revenue (%): 45.264752670862876
R&D to revenue (%): 4.6105660854926
Free cash flow (dilution-adjusted): 318472
Buyback yield (%): 0
Retained earnings: 10376317
Inventory turnover: 0.7471925623777079
Receivables turnover: 1.5985829329563765
Capitalized R&D asset: 114394
ROCI (R&D-adjusted, %): 6.275577101291432
FCF margin (%): 12.835779869389999
Rule of 40 score: 12.835779869389999
Financial ratios for UG — quarterly report dated 2025-06-30
Total revenue: 2838225
Gross profit: 1497371
Operating income: 695453
Net income: 626826
Capital expenditures: 17613
Operating cash flow: 303243
Depreciation & amortization: 25154
Net tangible assets: 11462575
Owner earnings: 634367
Return on net tangible assets (%): 5.534245141253165
Capex to operating income (%): 2.5325938632804803
Buffett classification: The Great
Stock price: 7.51
P/E ratio: 29.050034216789967
Shares outstanding: 4594319
Book value: 11462575
P/B ratio: 3.010085926591538
Market cap (USD): 34503335.69
Debt to equity: 0
Current ratio: 6.726260081760114
Quick ratio: 5.899801507549888
Effective tax rate (%): 20.71535361661114
COGS to revenue (%): 47.24269569889632
R&D to revenue (%): 3.800544354305948
Free cash flow (dilution-adjusted): 285630
Buyback yield (%): 0
Retained earnings: 11003143
Inventory turnover: 0.8753356308227419
Receivables turnover: 1.4879339070004938
Capitalized R&D asset: 184511.98
ROCI (R&D-adjusted, %): 6.219268453607656
Rosenberg metric: 1.2178960434987849
FCF margin (%): 10.063684168802684
Revenue growth (%): 14.392572407619603
Rule of 40 score: 24.456256576422287
Financial ratios for UG — quarterly report dated 2025-09-30
Total revenue: 2264261
Gross profit: 953069
Operating income: 215072
Net income: 268441
Capital expenditures: 15235
Operating cash flow: 1011001
Depreciation & amortization: 27301
Net tangible assets: 10582436
Owner earnings: 280507
Return on net tangible assets (%): 2.650684587178226
Capex to operating income (%): 7.083674304418985
Buffett classification: The Great
Stock price: 7.59
P/E ratio: 23.947116605157944
Shares outstanding: 4594319
Book value: 10582436
P/B ratio: 3.2951658020894246
Market cap (USD): 34870881.21
Debt to equity: 0
Current ratio: 7.038506573277953
Quick ratio: 6.156915068379989
Effective tax rate (%): 17.77593996477525
COGS to revenue (%): 57.90816518060418
R&D to revenue (%): 5.171841938716429
Free cash flow (dilution-adjusted): 995766
Buyback yield (%): 0
Retained earnings: 10123004
Inventory turnover: 0.9307795894521415
Receivables turnover: 1.9490876755935036
Capitalized R&D asset: 227125.58000000002
ROCI (R&D-adjusted, %): 2.0264836679897984
Rosenberg metric: -5.046000667482478
FCF margin (%): 43.97752732569258
Revenue growth (%): -20.222639149468417
Rule of 40 score: 23.75488817622416
Financial ratios for UG — quarterly report dated 2025-12-31
Total revenue: 2961855
Gross profit: 1332649
Operating income: 721901
Net income: 649576
Capital expenditures: 22539
Operating cash flow: 330495
Depreciation & amortization: 30715
Net tangible assets: 11232012
Owner earnings: 657752
Return on net tangible assets (%): 5.8560478745927265
Capex to operating income (%): 3.1221732619846767
Buffett classification: The Great
Stock price: 5.94
P/E ratio: 12.959947942241628
Shares outstanding: 4594319
Book value: 11232012
P/B ratio: 2.4296853368746403
Market cap (USD): 27290254.860000003
Debt to equity: 0
Current ratio: 7.3091975719469175
Quick ratio: 6.405978239056479
Effective tax rate (%): 20.587692349070085
COGS to revenue (%): 55.006271407614484
R&D to revenue (%): 4.195951523622865
Free cash flow (dilution-adjusted): 307956
Buyback yield (%): 0
Retained earnings: 10772580
Inventory turnover: 1.0805451519900675
Receivables turnover: 1.8664537973355415
Capitalized R&D asset: 238334.12
ROCI (R&D-adjusted, %): 6.24925349193763
Rosenberg metric: 3.2413922667031017
FCF margin (%): 10.397402978876414
Revenue growth (%): 30.808904097186673
Rule of 40 score: 41.206307076063084
Financial ratios for UG — annual report dated 2025-12-31
Total revenue: 10545468
Gross profit: 5141140
Operating income: 2243348
Net income: 2105738
Capital expenditures: 58995
Operating cash flow: 1966819
Depreciation & amortization: 108200
Net tangible assets: 11232012
Owner earnings: 2154943
Return on net tangible assets (%): 19.185725585051014
Capex to operating income (%): 2.6297747830474805
Buffett classification: The Great
Stock price: 5.94
P/E ratio: 12.959947942241628
Shares outstanding: 4594319
Book value: 11232012
P/B ratio: 2.4296853368746403
Market cap (USD): 27290254.860000003
Debt to equity: 0
Current ratio: 7.3091975719469175
Quick ratio: 6.405978239056479
Effective tax rate (%): 20.328185802956096
COGS to revenue (%): 51.247872545817785
R&D to revenue (%): 4.396618528452223
Free cash flow (dilution-adjusted): 1907824
Buyback yield (%): 0
Retained earnings: 10772580
Inventory turnover: 3.5843352038748795
Receivables turnover: 6.645372171588561
Capitalized R&D asset: 922803.2899999999
ROCI (R&D-adjusted, %): 18.164610906352607
Rosenberg metric: -2.888151600664654
FCF margin (%): 18.09141140061304
Revenue growth (%): -13.433811326590748
Rule of 40 score: 4.657600074022293
Financial ratios for UONEK — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 33.9
Shares outstanding: 3411761
Market cap (USD): 115658697.89999999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for UONEK — annual report dated 2022-12-31
Total revenue: 484604000
Gross profit: 361968000
Operating income: 131772000
Net income: 36660000
Capital expenditures: 28683000
Operating cash flow: 66548000
Depreciation & amortization: 66663000
Net tangible assets: -515839000
Owner earnings: 74640000
Return on net tangible assets (%): -14.469631028285956
Capex to operating income (%): 21.767143247427377
Buffett classification: The Great
Stock price: 37.6
P/E ratio: 3.4992420512820512
Shares outstanding: 3411761
Book value: 362673000
P/B ratio: 0.3537131619944137
Market cap (USD): 128282213.60000001
Debt to equity: 2.132044569074621
Current ratio: 2.224141306148263
Quick ratio: 2.224141306148263
Effective tax rate (%): 30.931836165643016
Interest coverage ratio: 2.1339249566808633
COGS to revenue (%): 25.30643577023714
SG&A to revenue (%): 45.43132124373715
Free cash flow (dilution-adjusted): 24873000
Buyback yield (%): 20.691099143926838
Retained earnings: -736010000
Receivables turnover: 3.411623077193847
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.873820377149231
FCF margin (%): 5.132644385931606
Rule of 40 score: 5.132644385931606
Financial ratios for UONEK — annual report dated 2023-12-31
Total revenue: 477690000
Gross profit: 340667000
Operating income: 97707000
Net income: 4565000
Capital expenditures: 30201000
Operating cash flow: 64645000
Depreciation & amortization: 62179000
Net tangible assets: -449382000
Owner earnings: 36543000
Return on net tangible assets (%): -8.131834385889954
Capex to operating income (%): 30.9097608154994
Buffett classification: The Good
Stock price: 35.3
P/E ratio: 26.382292070098572
Shares outstanding: 3411761
Book value: 290585000
P/B ratio: 0.41445760551989946
Market cap (USD): 120435163.3
Debt to equity: 2.578491663368722
Current ratio: 3.1815275578677524
Quick ratio: 3.1815275578677524
Effective tax rate (%): 45.034013605442176
Interest coverage ratio: 1.7386824685030964
COGS to revenue (%): 28.68450250162239
SG&A to revenue (%): 49.37490841340618
Free cash flow (dilution-adjusted): 19494000
Buyback yield (%): 1.3534253247448371
Retained earnings: -733371000
Receivables turnover: 3.586422811838371
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.059165930333792
FCF margin (%): 4.080889279658355
Revenue growth (%): -1.4267319295754886
Rule of 40 score: 2.6541573500828664
Financial ratios for UONEK — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 11.1
Shares outstanding: 3411761
Market cap (USD): 37870547.1
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for UONEK — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 10
Shares outstanding: 3411761
Market cap (USD): 34117610
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for UONEK — annual report dated 2024-12-31
Total revenue: 449674000
Gross profit: 314336000
Operating income: 76170000
Net income: -104179000
Capital expenditures: 1863000
Operating cash flow: 37478000
Depreciation & amortization: 58993000
Net tangible assets: -400968000
Owner earnings: -47049000
Capex to operating income (%): 2.445844820795589
Buffett classification: The Great
Stock price: 10
Shares outstanding: 3411761
Book value: 178933000
P/B ratio: 0.19067254223647956
Market cap (USD): 34117610
Debt to equity: 3.4139594149765555
Current ratio: 2.6716855348112896
Quick ratio: 2.6716855348112896
Interest coverage ratio: 1.568219719585761
COGS to revenue (%): 30.09691465372692
SG&A to revenue (%): 51.24823761213679
Free cash flow (dilution-adjusted): 24286000
Buyback yield (%): 23.835198303749884
Retained earnings: -838765000
Receivables turnover: 3.949809832494488
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.171715906792151
FCF margin (%): 5.400801469509022
Revenue growth (%): -5.864891456802529
Rule of 40 score: -0.4640899872935069
Financial ratios for UONEK — quarterly report dated 2025-03-31
Total revenue: 92235000
Gross profit: 61622000
Operating income: 8541000
Net income: -11739000
Capital expenditures: 2547000
Operating cash flow: 2085000
Depreciation & amortization: 13442000
Net tangible assets: -399813000
Owner earnings: -844000
Capex to operating income (%): 29.820864067439413
Buffett classification: The Good
Stock price: 7.2
Shares outstanding: 3411761
Book value: 162956000
P/B ratio: 0.15074424507228945
Market cap (USD): 24564679.2
Debt to equity: 3.5826419401556246
Current ratio: 2.9605220301672337
Quick ratio: 2.9605220301672337
Effective tax rate (%): 399.5406991579485
Interest coverage ratio: 0.7818564628341267
COGS to revenue (%): 33.19022063208109
SG&A to revenue (%): 55.03984387705317
Free cash flow (dilution-adjusted): -1138000
Buyback yield (%): 4.058672990934073
Retained earnings: -850507000
Receivables turnover: 0.9797225526852481
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.0656083362236966
FCF margin (%): -1.2338049547351873
Rule of 40 score: -1.2338049547351873
Financial ratios for UONEK — quarterly report dated 2025-06-30
Total revenue: 91631000
Gross profit: 62970000
Operating income: 9394000
Net income: -77902000
Capital expenditures: 1218000
Operating cash flow: 6205000
Depreciation & amortization: 13737000
Net tangible assets: -344460000
Owner earnings: -65383000
Capex to operating income (%): 12.965722801788376
Buffett classification: The Great
Stock price: 6.4
Shares outstanding: 3411761
Book value: 84759000
P/B ratio: 0.2576159511084369
Market cap (USD): 21835270.400000002
Debt to equity: 6.161056642952371
Current ratio: 2.635739414712503
Quick ratio: 2.635739414712503
Interest coverage ratio: 0.9680544105523495
COGS to revenue (%): 31.278715718479553
SG&A to revenue (%): 54.624526633999416
Free cash flow (dilution-adjusted): 4413000
Buyback yield (%): 3.3386350919657035
Retained earnings: -928409000
Receivables turnover: 0.9765015559060488
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.4659205462949383
FCF margin (%): 4.816055701673014
Revenue growth (%): -0.6548490269420502
Rule of 40 score: 4.161206674730964
Financial ratios for UONEK — quarterly report dated 2025-09-30
Total revenue: 92677000
Gross profit: 57958000
Operating income: 2510000
Net income: -2821000
Capital expenditures: 3100000
Operating cash flow: -161000
Depreciation & amortization: 18433000
Net tangible assets: -340657000
Owner earnings: 12512000
Capex to operating income (%): 123.50597609561753
Buffett classification: The Gruesome
Stock price: 7
Shares outstanding: 3411761
Book value: 81418000
P/B ratio: 0.2933298165024933
Market cap (USD): 23882327
Debt to equity: 6.412500921172223
Current ratio: 2.5858974648396056
Quick ratio: 2.5858974648396056
Interest coverage ratio: 0.26566469093988143
COGS to revenue (%): 37.46236930414234
SG&A to revenue (%): 53.24298369606267
Free cash flow (dilution-adjusted): -3626000
Buyback yield (%): 3.374880513109129
Retained earnings: -931239000
Receivables turnover: 0.9880803880803881
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.3953490569901179
FCF margin (%): -3.9125133528275624
Revenue growth (%): 1.141535070009058
Rule of 40 score: -2.770978282818504
Financial ratios for UONEK — quarterly report dated 2025-12-31
Total revenue: 97828000
Gross profit: 66377000
Operating income: 1250000
Net income: -54350000
Capital expenditures: 3207000
Operating cash flow: -3969000
Depreciation & amortization: 18692000
Net tangible assets: -325972000
Owner earnings: -38865000
Capex to operating income (%): 256.56
Buffett classification: The Gruesome
Stock price: 8.6
Shares outstanding: 3411761
Book value: 27234000
P/B ratio: 1.077371836674745
Market cap (USD): 29341144.599999998
Debt to equity: 17.58783138723654
Current ratio: 2.1000395867652504
Quick ratio: 2.1000395867652504
Interest coverage ratio: 0.143184421534937
COGS to revenue (%): 32.14928241403279
SG&A to revenue (%): 60.305842907960916
Free cash flow (dilution-adjusted): -7468000
Buyback yield (%): 0.777065799948377
Retained earnings: -985634000
Receivables turnover: 1.1032071811989714
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.24286699631813632
FCF margin (%): -7.633806272232898
Revenue growth (%): 5.55801331506199
Rule of 40 score: -2.0757929571709086
Financial ratios for UONEK — annual report dated 2025-12-31
Total revenue: 374371000
Gross profit: 248927000
Operating income: 21695000
Net income: -146869000
Capital expenditures: 10322000
Operating cash flow: 4160000
Depreciation & amortization: 64304000
Net tangible assets: -325972000
Owner earnings: -92887000
Capex to operating income (%): 47.577782899285545
Buffett classification: The Good
Stock price: 8.6
Shares outstanding: 3411761
Book value: 27234000
P/B ratio: 1.077371836674745
Market cap (USD): 29341144.599999998
Debt to equity: 17.58783138723654
Current ratio: 2.1000395867652504
Quick ratio: 2.1000395867652504
Interest coverage ratio: 0.5590630314899758
COGS to revenue (%): 33.50793731352055
SG&A to revenue (%): 55.869445015773124
Free cash flow (dilution-adjusted): -8069000
Buyback yield (%): 9.40658599937509
Retained earnings: -985634000
Receivables turnover: 4.221784924895124
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.215199588097574
FCF margin (%): -2.1553485713369893
Revenue growth (%): -16.74613164203401
Rule of 40 score: -18.901480213371
Financial ratios for VIK — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 61052000
Buffett classification: The Gruesome
Stock price: 34.89
Shares outstanding: 318386000
Market cap (USD): 11108487540
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VIK — annual report dated 2024-12-31
Total revenue: 5333882000
Gross profit: 2219801000
Operating income: 1075068000
Net income: 152977000
Capital expenditures: 917424000
Operating cash flow: 2082009000
Depreciation & amortization: 260844000
Net tangible assets: -283788000
Owner earnings: -503603000
Capex to operating income (%): 85.33636942035294
Buffett classification: The Gruesome
Stock price: 44.06
P/E ratio: 91.70062924491918
Shares outstanding: 318386000
Book value: -218977000
Market cap (USD): 14028087160
Debt to equity: -25.447709120135904
Current ratio: 0.6161285224875085
Quick ratio: 0.5986068557713581
Effective tax rate (%): 9.925574384398884
Interest coverage ratio: 2.8529030100866963
COGS to revenue (%): 58.38301259757902
SG&A to revenue (%): 16.57121398636115
Free cash flow (dilution-adjusted): 1150474000
Buyback yield (%): 0
Retained earnings: -5288833000
Inventory turnover: 34.043717818372635
Receivables turnover: 22.31581721878687
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 21.93962596834363
FCF margin (%): 21.56916857178318
Revenue growth (%): 13.234050024063299
Rule of 40 score: 34.80321859584648
Financial ratios for VIK — quarterly report dated 2024-12-31
Capital expenditures: 0
Depreciation & amortization: 73740000
Buffett classification: The Gruesome
Stock price: 44.06
Shares outstanding: 318386000
Market cap (USD): 14028087160
Buyback yield (%): 0
Retained earnings: -5288833000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VIK — quarterly report dated 2025-03-31
Total revenue: 897056000
Gross profit: 303395000
Operating income: -9267000
Net income: -105452000
Capital expenditures: 146294000
Operating cash flow: 587885000
Depreciation & amortization: 68800000
Net tangible assets: -271226000
Owner earnings: -182946000
Buffett classification: The Gruesome
Stock price: 39.75
Shares outstanding: 318386000
Book value: -267474000
Market cap (USD): 12655843500
Debt to equity: -20.697413580385383
Current ratio: 0.6278355851979858
Quick ratio: 0.6122492421818978
Interest coverage ratio: -0.10688088208156486
COGS to revenue (%): 66.17881157921022
SG&A to revenue (%): 27.184701958406166
Free cash flow (dilution-adjusted): 427383000
Buyback yield (%): 0
Retained earnings: -5394401000
Inventory turnover: 6.470701719965993
Receivables turnover: 3.863806106758439
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.19236613459277416
FCF margin (%): 47.64284503977455
Rule of 40 score: 47.64284503977455
Financial ratios for VIK — quarterly report dated 2025-06-30
Total revenue: 1880367000
Gross profit: 859265000
Operating income: 545532000
Net income: 439237000
Capital expenditures: 668088000
Operating cash flow: 470681000
Depreciation & amortization: 65440000
Net tangible assets: 204441000
Owner earnings: -163411000
Return on net tangible assets (%): -79.9306401357849
Capex to operating income (%): 122.46540991179253
Buffett classification: The Gruesome
Stock price: 53.29
P/E ratio: 50.83149314678611
Shares outstanding: 318386000
Book value: 278320000
P/B ratio: 60.96144703937913
Market cap (USD): 16966789940
Debt to equity: 20.332020695602186
Current ratio: 0.6401752299027865
Quick ratio: 0.6231467775141722
Effective tax rate (%): 1.0355246230000923
Interest coverage ratio: 6.496129938793493
COGS to revenue (%): 54.30333546589575
SG&A to revenue (%): 13.204496781745265
Free cash flow (dilution-adjusted): -219564000
Buyback yield (%): 0
Retained earnings: -4955353000
Inventory turnover: 11.090014553511306
Receivables turnover: 10.979347673766815
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.553140627465305
FCF margin (%): -11.676656737753852
Revenue growth (%): 109.61534174009205
Rule of 40 score: 97.93868500233819
Financial ratios for VIK — quarterly report dated 2025-09-30
Total revenue: 1999638000
Gross profit: 941470000
Operating income: 604712000
Net income: 514089000
Capital expenditures: 54547000
Operating cash flow: 663937000
Depreciation & amortization: 69716000
Net tangible assets: 732000000
Owner earnings: 529258000
Return on net tangible assets (%): 72.30300546448088
Capex to operating income (%): 9.020327031710963
Buffett classification: The Great
Stock price: 62.16
P/E ratio: 23.341762761919814
Shares outstanding: 318386000
Book value: 803536000
P/B ratio: 24.6297287987097
Market cap (USD): 19790873760
Debt to equity: 7.026913542143725
Current ratio: 0.6305639200836155
Quick ratio: 0.6144303434608661
Effective tax rate (%): 1.325744123321463
Interest coverage ratio: 5.653838961816074
COGS to revenue (%): 52.91797815404588
SG&A to revenue (%): 13.354517167607337
Free cash flow (dilution-adjusted): 581287000
Buyback yield (%): 0
Retained earnings: -4441264000
Inventory turnover: 10.731382789919376
Receivables turnover: 15.361388306330806
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.176966479562008
FCF margin (%): 29.069611599699545
Revenue growth (%): 6.342963900132262
Rule of 40 score: 35.41257549983181
Financial ratios for VIK — annual report dated 2025-12-31
Total revenue: 6501419000
Gross profit: 2817559000
Operating income: 1501534000
Net income: 1148095000
Capital expenditures: 1026854000
Operating cash flow: 2560310000
Depreciation & amortization: 284790000
Net tangible assets: 1007033000
Owner earnings: 406031000
Return on net tangible assets (%): 40.31953272633568
Capex to operating income (%): 68.38699623185356
Buffett classification: The Good
Stock price: 71.41
P/E ratio: 19.803190728990195
Shares outstanding: 318386000
Book value: 1121342000
P/B ratio: 20.27565565188854
Market cap (USD): 22735944260
Debt to equity: 5.11966554360757
Current ratio: 0.7876131332026765
Quick ratio: 0.770860367675803
Effective tax rate (%): 1.6829829723536243
Interest coverage ratio: 4.404578428467922
COGS to revenue (%): 56.6623993931171
SG&A to revenue (%): 15.861691116970004
Free cash flow (dilution-adjusted): 1444938000
Buyback yield (%): 0
Retained earnings: -4164681000
Inventory turnover: 38.46168302359574
Receivables turnover: 45.77078067909014
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 23.04577341030739
FCF margin (%): 22.224963504121177
Revenue growth (%): 21.889066912241404
Rule of 40 score: 44.11403041636258
Financial ratios for VIK — quarterly report dated 2025-12-31
Total revenue: 1724358000
Gross profit: 713429000
Operating income: 360557000
Net income: 300301000
Capital expenditures: 157925000
Operating cash flow: 837807000
Depreciation & amortization: 80834000
Net tangible assets: 1007033000
Owner earnings: 223210000
Return on net tangible assets (%): 22.165112761945238
Capex to operating income (%): 43.80028677851214
Buffett classification: The Good
Stock price: 71.41
P/E ratio: 19.801810926034793
Shares outstanding: 318386000
Book value: 1121342000
P/B ratio: 20.27565565188854
Market cap (USD): 22735944260
Debt to equity: 5.11966554360757
Current ratio: 0.7876131332026765
Quick ratio: 0.770860367675803
Effective tax rate (%): 1.6325728417708043
Interest coverage ratio: 5.699154350746858
COGS to revenue (%): 58.62639892644103
SG&A to revenue (%): 15.776190327066653
Free cash flow (dilution-adjusted): 655832000
Buyback yield (%): 0
Retained earnings: -4164681000
Inventory turnover: 10.554698266861557
Receivables turnover: 12.139690093844822
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.533883963666625
FCF margin (%): 38.03340141664318
Revenue growth (%): -13.766491735004035
Rule of 40 score: 24.266909681639145
Financial ratios for VIKRAN.NS — quarterly report dated 2025-09-30
Total revenue: 19874859.075535513
Gross profit: 7694475.760992108
Operating income: 2801578.3540022545
Net income: 1030439.6843291995
Capital expenditures: 0
Depreciation & amortization: 66516.34723788049
Net tangible assets: 130817361.8940248
Owner earnings: 1096956.03156708
Return on net tangible assets (%): 0.8385400956607919
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.0697857948139797
P/E ratio: 66.93976273834792
Shares outstanding: 257911026
Book value: 130838782.41262683
P/B ratio: 2.108774988982715
Market cap (USD): 275909551.940699
Debt to equity: 0.27395867441018834
Current ratio: 2.363306834658267
Quick ratio: 2.2832108394580275
Effective tax rate (%): 6.639427987742595
Interest coverage ratio: 1.3767313019390581
COGS to revenue (%): 61.28538204095524
Buyback yield (%): 0
Inventory turnover: 1.6860174781523094
Receivables turnover: 0.28756687981208406
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.1242947512395283
Revenue growth (%): -52.157156456414576
Rule of 40 score: -52.157156456414576
Financial ratios for VIKRAN.NS — quarterly report dated 2025-12-31
Total revenue: 29682522.000668377
Gross profit: 8392558.761278825
Operating income: 3752924.139467528
Net income: 2329285.952990977
Capital expenditures: 0
Depreciation & amortization: 129219.11551743344
Owner earnings: 2458505.0685084104
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.1147376629163417
P/E ratio: 24.57312703590943
Shares outstanding: 257911026
Market cap (USD): 287503134.36359584
Effective tax rate (%): 19.328703703703702
Interest coverage ratio: 2.5796324655436447
COGS to revenue (%): 71.7255873301809
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 49.347081596192915
Rule of 40 score: 49.347081596192915
Financial ratios for XMAX — annual report dated 2021-12-31
Capital expenditures: 110519
Buffett classification: The Gruesome
Stock price: 9.35
Shares outstanding: 63602326
Market cap (USD): 594681748.1
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for XMAX — annual report dated 2022-12-31
Total revenue: 12744871
Gross profit: -7781613
Operating income: -16222351
Net income: -17101671
Capital expenditures: 8772
Operating cash flow: -5367650
Depreciation & amortization: 571848
Net tangible assets: 6379387
Owner earnings: -16538595
Return on net tangible assets (%): -259.2505361408549
Buffett classification: The Gruesome
Stock price: 2.15
Shares outstanding: 63602326
Book value: 6611830
P/B ratio: 20.681868847202665
Market cap (USD): 136745000.9
Debt to equity: 0.4322273863665581
Current ratio: 4.9920379965142265
Quick ratio: 1.9892309930680225
COGS to revenue (%): 161.0568204260365
R&D to revenue (%): 0.08565798743667158
SG&A to revenue (%): 66.14285072010536
Free cash flow (dilution-adjusted): -5950345
Buyback yield (%): 0
Retained earnings: -36706553
Inventory turnover: 4.16135693610037
Receivables turnover: 34.66548892569896
Capitalized R&D asset: 10917
ROCI (R&D-adjusted, %): -163.7599002841522
FCF margin (%): -46.68815400328493
Rule of 40 score: -46.68815400328493
Financial ratios for XMAX — annual report dated 2023-12-31
Total revenue: 11087459
Gross profit: 4173557
Operating income: -6418548
Net income: -7723257
Capital expenditures: 18643
Operating cash flow: -1580247
Depreciation & amortization: 803790
Net tangible assets: 269275
Owner earnings: -6938110
Return on net tangible assets (%): -2576.588988951815
Buffett classification: The Gruesome
Stock price: 3.77
Shares outstanding: 63602326
Book value: 496354
P/B ratio: 483.08418793844714
Market cap (USD): 239780769.02
Debt to equity: 4.254360798945914
Current ratio: 1.0162785743094678
Quick ratio: 0.416356040991747
Interest coverage ratio: -675.9924170616114
COGS to revenue (%): 62.35785854991662
R&D to revenue (%): 28.122999147054344
SG&A to revenue (%): 67.40930451242255
Free cash flow (dilution-adjusted): -2079878
Buyback yield (%): 0
Retained earnings: -44429810
Inventory turnover: 3.123782423708191
Receivables turnover: 125.61842448137952
Capitalized R&D asset: 3125440.39
ROCI (R&D-adjusted, %): -76.54184768979128
Rosenberg metric: 1095.0966382705872
FCF margin (%): -18.75883374179783
Revenue growth (%): -13.004541199357767
Rule of 40 score: -31.763374941155597
Financial ratios for XMAX — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.53
Shares outstanding: 63602326
Market cap (USD): 97311558.78
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0